Dalhousie University.
Université du Québec à Trois-Rivières.
Behav Ther. 2021 Nov;52(6):1502-1515. doi: 10.1016/j.beth.2021.05.002. Epub 2021 May 13.
Provoked vestibulodynia is a vulvar pain condition causing sexual dysfunction, affecting 8% to 10% of women. Our recently published randomized clinical trial (N = 108 couples) found that cognitive behavioral couple therapy (CBCT) and topical lidocaine reduced women's pain and associated sexual symptoms, with CBCT showing more benefits. Little is known about pretreatment predictors of treatment outcomes in couples sex therapy. In the current study, we examined women and their partners' pretreatment demographic (age, relationship length), clinical (pain duration, anxiety) and interpersonal (partner responses to pain, sexual goals) predictors/moderators of women's pain intensity, pain unpleasantness, and sexual function at posttreatment and 6-month follow-up. Longer relationship duration, lower anxiety in women, partner higher solicitousness and partner higher approach sexual goals predicted better pain outcomes for women with PVD irrespective of treatment condition. CBCT was more effective than lidocaine for improving women's sexual function at posttreatment when, at pretreatment, women had partners with higher anxiety and women reported lower approach sexual goals, whereas lidocaine was more effective for improving women's sexual function at follow-up when partners had higher approach sexual goals. Findings can assist clinicians in determining what treatment will be most beneficial for whom.
诱发性外阴痛是一种外阴疼痛疾病,导致性功能障碍,影响 8%至 10%的女性。我们最近发表的一项随机临床试验(N=108 对夫妇)发现,认知行为夫妻治疗(CBCT)和局部利多卡因可减轻女性疼痛和相关的性症状,CBCT 显示出更多的益处。对于夫妻性治疗中治疗结果的预处理预测因素知之甚少。在当前的研究中,我们检查了女性及其伴侣的预处理人口统计学(年龄、关系持续时间)、临床(疼痛持续时间、焦虑)和人际关系(伴侣对疼痛的反应、性目标)预测因素/调节者,这些因素/调节者预测了女性在治疗后和 6 个月随访时的疼痛强度、疼痛不适和性功能。关系持续时间较长、女性焦虑程度较低、伴侣更关心和伴侣更接近性目标,这些都预示着 PVD 女性的疼痛结果更好,而无论治疗条件如何,CBCT 都比利多卡因更能有效改善女性的性功能。当女性的伴侣有更高的焦虑和女性报告更低的接近性目标时,CBCT 在治疗后更能有效改善女性的性功能,而当伴侣有更高的接近性目标时,利多卡因在随访时更能有效改善女性的性功能。这些发现可以帮助临床医生确定哪种治疗对谁最有益。